KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Equity Ratio (2018 - 2021)

BioNTech SE's Equity Ratio history spans 4 years, with the latest figure at 0.75 for Q4 2021.

  • For Q4 2021, Equity Ratio rose 26.98% year-over-year to 0.75; the TTM value through Dec 2021 reached 0.75, up 26.98%, while the annual FY2021 figure was 0.75, 26.98% up from the prior year.
  • Equity Ratio for Q4 2021 was 0.75 at BioNTech SE, up from 0.59 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.75 in Q4 2021 and bottomed at 0.41 in Q4 2018.
  • The 4-year median for Equity Ratio is 0.61 (2019), against an average of 0.59.
  • The largest annual shift saw Equity Ratio surged 51.31% in 2019 before it fell 4.37% in 2020.
  • A 4-year view of Equity Ratio shows it stood at 0.41 in 2018, then surged by 51.31% to 0.62 in 2019, then dropped by 4.37% to 0.59 in 2020, then grew by 26.98% to 0.75 in 2021.
  • Per Business Quant, the three most recent readings for BNTX's Equity Ratio are 0.75 (Q4 2021), 0.59 (Q4 2020), and 0.62 (Q4 2019).